These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1565636)

  • 21. Stabilization of the β-hairpin in Mason-Pfizer monkey virus capsid protein- a critical step for infectivity.
    Obr M; Hadravová R; DoleŽal M; KříŽová I; Papoušková V; Zídek L; Hrabal R; Ruml T; Rumlová M
    Retrovirology; 2014 Oct; 11():94. PubMed ID: 25365920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity.
    Dubay JW; Roberts SJ; Brody B; Hunter E
    J Virol; 1992 Aug; 66(8):4748-56. PubMed ID: 1629954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
    Yu X; Yuan X; Matsuda Z; Lee TH; Essex M
    J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A myristoyl switch at the plasma membrane triggers cleavage and oligomerization of Mason-Pfizer monkey virus matrix protein.
    Častorálová M; Sýs J; Prchal J; Pavlů A; Prokopová L; Briki Z; Hubálek M; Ruml T
    Elife; 2024 Mar; 13():. PubMed ID: 38517277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RNA binding G-patch domain in retroviral protease is important for infectivity and D-type morphogenesis of Mason-Pfizer monkey virus.
    Bauerová-Zábranská H; Stokrová J; Strísovsky K; Hunter E; Ruml T; Pichová I
    J Biol Chem; 2005 Dec; 280(51):42106-12. PubMed ID: 16257973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-directed mutagenesis of the P2 region of the Rous sarcoma virus gag gene: effects on Gag polyprotein processing.
    Bowles N; Bonnet D; Mulhauser F; Spahr PF
    Virology; 1994 Aug; 203(1):20-8. PubMed ID: 8030280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein.
    Choi G; Park S; Choi B; Hong S; Lee J; Hunter E; Rhee SS
    J Virol; 1999 Jul; 73(7):5431-7. PubMed ID: 10364290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Mason-Pfizer monkey virus CA-NC spacer peptide-like domain in assembly of immature particles.
    Strohalmová-Bohmová K; Spiwok V; Lepšík M; Hadravová R; Křížová I; Ulbrich P; Pichová I; Bednárová L; Ruml T; Rumlová M
    J Virol; 2014 Dec; 88(24):14148-60. PubMed ID: 25275119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rescue of internal scaffold-deleted Mason-Pfizer monkey virus particle production by plasma membrane targeting.
    Sakalian M; Rapp ND
    Virology; 2006 Feb; 345(2):317-27. PubMed ID: 16297423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation.
    Dubay JW; Dubay SR; Shin HJ; Hunter E
    J Virol; 1995 Aug; 69(8):4675-82. PubMed ID: 7609032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virus.
    Kohoutová Z; Rumlová M; Andreánsky M; Sakalian M; Hunter E; Pichová I; Ruml T
    Virology; 2009 Feb; 384(1):59-68. PubMed ID: 19062065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of point mutations within the N-terminal domain of Mason-Pfizer monkey virus capsid protein on virus core assembly and infectivity.
    Wildová M; Hadravová R; Stokrová J; Krízová I; Ruml T; Hunter E; Pichová I; Rumlová M
    Virology; 2008 Oct; 380(1):157-63. PubMed ID: 18755489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus.
    Rhee SS; Hunter E
    Cell; 1990 Oct; 63(1):77-86. PubMed ID: 2170021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
    González SA; Affranchino JL
    Virology; 1998 Jan; 240(1):27-35. PubMed ID: 9448686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of soluble surface glycoprotein, GP70, of the Mason-Pfizer monkey virus in COS cells is dependent on the presence of regions of the transmembrane domain.
    Allen JM; Ali M; McClure MO
    Biochem Soc Trans; 1995 May; 23(2):334S. PubMed ID: 7672366
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape.
    Rumlova-Klikova M; Hunter E; Nermut MV; Pichova I; Ruml T
    J Virol; 2000 Sep; 74(18):8452-9. PubMed ID: 10954545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
    González SA; Affranchino JL
    Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Mason-Pfizer monkey virus internal scaffold domain enables in vitro assembly of human immunodeficiency virus type 1 Gag.
    Sakalian M; Dittmer SS; Gandy AD; Rapp ND; Zábranský A; Hunter E
    J Virol; 2002 Nov; 76(21):10811-20. PubMed ID: 12368324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1H, 13C, and 15N resonance assignment of the N-terminal domain of Mason-Pfizer monkey virus capsid protein, CA 1-140.
    Macek P; Zídek L; Rumlová M; Pichová I; Sklenár V
    Biomol NMR Assign; 2008 Jun; 2(1):43-5. PubMed ID: 19636921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The conserved dileucine- and tyrosine-based motifs in MLV and MPMV envelope glycoproteins are both important to regulate a common Env intracellular trafficking.
    Blot V; Lopez-Vergès S; Breton M; Pique C; Berlioz-Torrent C; Grange MP
    Retrovirology; 2006 Sep; 3():62. PubMed ID: 16978406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.